FAQs
Find answers about Nova, our products and working with us. If you need more information, we’ll help you reach the right team.
About Nova
We source, manufacture, register, supply and distribute pharmaceutical and health products.
Nova Pharmaceuticals is a privately owned Australian company founded by David Mohammed, who also serves as the company’s Chief Executive Officer.
We’re based in Australia, with our headquarters in Bella Vista, New South Wales.
Address: Suite 305, 10 Norbrik Drive, Bella Vista NSW 2153
Our range includes consumer healthcare products, prescription medicines, over-the-counter (OTC) medicines and medical devices. To view our full range, visit our Products page.
Products & Information
Nova products are available at major supermarkets, including Woolworths and Coles, and the majority of pharmacies across Australia. You can also purchase them online through retailers such as Amazon.
Stock can vary by store, so check with your local supermarket or pharmacy before you visit.
Nova does not sell directly to patients or consumers. Our products are only available through our retail partners, including major supermarkets, pharmacies and online retailers.
No. Always consult your pharmacist or doctor.
Please contact pv@novapharm.com.au to report any adverse events or product quality issues.
Please contact pv@novapharm.com.au for all product enquiries.
Partnerships & Enquiries
Whether you are an established multinational or a local start-up, Nova can offer you a range of services, from development through to distribution and beyond.
For all licensing opportunities, including in-licensing and out-licensing, you can reach our Business Development Team at info@novapharm.com.au.
All pharmacies and providers in Australia have a dedicated Nova Representative.
You can contact Nova at info@novapharm.com.au, and our Customer Service Team will connect you with your dedicated Nova Representative.
Nova products are available via pharmacy wholesalers.
Nova is a leading private label supplier of over-the-counter (OTC) and consumer medicinal ranges to Australian pharmacies and major supermarket chains, including Coles, Woolworths, Aldi and Metcash.
You can contact Nova at info@novapharm.com.au for all private label enquiries.
Generic Medicines
A generic medicine is a pharmaceutical product containing the same active ingredient(s) as a brand-name medicine, often offered at a lower cost.
Before supply, generic medicines must be proven to be bioequivalent. In practice, this means they have the same dosage form, strength, route of administration, quality, performance characteristics and intended use.
The active ingredient, strength and dosage form match the originator brand. However, some inactive ingredients (such as binders or colourings) may differ.
Yes. Before a generic medicine can be supplied in Australia, the Therapeutic Goods Administration (TGA) must assess its quality, safety and effectiveness. The TGA requires all generic medicines to demonstrate that they work the same way in the body as the originator brand.
No. Generic medicines are held to the same stringent quality, manufacturing and safety standards as originator brands.
Developing a new medicine takes years of research and large clinical trials, the costs of which originator companies need to recover. Generic manufacturers do not need to repeat the original discovery, so we can bring medicines to market at more affordable prices. The difference in cost reflects a different cost structure, not a difference in quality.
The value of a medicine is only realised when patients can access it.
When a brand’s market exclusivity expires, generic entry introduces competition, which reduces prices and broadens availability. Without generic competition, a single supplier could retain control of the market, and high prices would limit who could access treatment.
In Australia, increased generic uptake sustains the Pharmaceutical Benefits Scheme (PBS), releases savings for reinvestment, and strengthens supply and choice. Every generic medicine dispensed through a community pharmacy contributes to these system-wide savings.

Together, We BringMedicine Closer
Connect with Nova to explore opportunities across research and development, manufacturing and commercialisation. Let’s discuss how our combined expertise can bring quality medicines to more people.
Work with Us
